Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...
In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...
GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...
GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are ...
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.
A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback